O-GlcNAc transferase inhibits KSHV propagation and modifies replication relevant viral proteins as detected by systematic O-GlcNAcylation analysis

Glycobiology

Volumn 23, Issue 10, 2013, Pages 1114-1130

  Jochmann, Ramona ^a   Pfannstiel, Jens ^b   Chudasama, Priya ^a   Kuhn, Elisabeth ^a   Konrad, Andreas ^a   Stürzl, Michael ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF HOHENHEIM   (Germany)

Author keywords

DNA replication; DNA synthesis; Kaposi's sarcoma; KSHV; O GlcNAc

Indexed keywords

DOXYCYCLINE; N ACETYLGLUCOSAMINE; N ACETYLGLUCOSAMINE TRANSFERASE; ORF K10 PROTEIN; ORF K10.5 PROTEIN; ORF K11 PROTEIN; ORF K3 PROTEIN; ORF K8 PROTEIN; ORF17 PROTEIN; ORF2 PROTEIN; ORF21 PROTEIN; ORF25 PROTEIN; ORF29 PROTEIN; ORF44 PROTEIN; ORF54 PROTEIN; ORF59 PROTEIN; ORF60 PROTEIN; ORF63 PROTEIN; ORF69 PROTEIN; ORF75 PROTEIN; ORF8 PROTEIN; ORF9 PROTEIN; TRANSFERASE; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

ACYLATION; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; DNA REPLICATION; DNA SYNTHESIS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; IMMUNE RESPONSE; IMMUNOPRECIPITATION; MASS SPECTROMETRY; NONHUMAN; NUCLEOTIDE METABOLISM; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN ASSEMBLY; VIRUS REPLICATION;

DNA REPLICATION; DNA SYNTHESIS; KAPOSI'S SARCOMA; KSHV; O-GLCNAC;

HEK293 CELLS; HERPESVIRUS 8, HUMAN; HUMANS; N-ACETYLGLUCOSAMINYLTRANSFERASES; OPEN READING FRAMES; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84887929058     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwt028     Document Type: Article

References (132)

1. Arumugaswami V, Wu T-T, Martinez-Guzman D, Jia Q., Deng H, Reyes N, Sun R. 2006. ORF18 Is a transfactor that is essential for late gene transcription of a gammaherpesvirus. J Virol. 80: 9730-9740.
2. Baghian A, Luftig M, Black J.B., Meng YX, Pau CP, Voss T, Pellett P.E., Kousoulas KG 2000. Glycoprotein B of human herpesvirus 8 is a component of the virion in a cleaved form composed of amino- and carboxyl-terminal fragments. Virology. 269: 18-25.
3. Bais C, Santomasso B, Coso O., Arvanitakis L, Raaka EG, Gutkind J.S., Asch AS, Cesarman E, Gershengorn MC, Mesri EA 1998. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature. 391: 86-89.
4. Ballestas ME, Chatis PA, Kaye KM 1999. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science. 284: 641-644.
5. Baresova P, Pitha PM, Lubyova B. 2012. Kaposi sarcoma-associated herpesvirus vIRF-3 protein binds to F-box of Skp2 protein and acts as a regulator of c-Myc protein function and stability. J Biol Chem. 287: 16199-16208.
6. Bechtel JT, Winant RC, Ganem D. 2005. Host and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirus. J Virol. 79: 4952-4964.
7. Bisson SA, Page A-L, Ganem D. 2009. A Kaposi's sarcoma-associated herpesvirus protein that forms inhibitory complexes with type I interferon receptor subunits, Jak and STAT proteins, and blocks interferon-mediated signal transduction. J Virol. 83: 5056-5066.
8. Brinkmann MM, Glenn M, Rainbow L., Kieser A, Henke-Gendo C, Schulz TF 2003. Activation of mitogen-activated protein kinase and NF-kappaB pathways by a Kaposi's sarcoma-associated herpesvirus K15 membrane protein. J Virol. 77: 9346-9358.
9. Butkinaree C, Park K, Hart GW 2010. O-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress. Biochim Biophys Acta. 1800: 96-106.
10. Casper C, Krantz EM, Corey L, Kuntz S.R., Wang J., Selke S, Hamilton S, Huang M-L, Wald A. 2008. Valganciclovir for suppression of human herpesvirus-8 peplication: A randomized, double-blind, placebo-controlled, crossover trial. J Infect Dis. 198: 23-30.
11. Chang Y, Cesarman E, Pessin M.S., Lee F., Culpepper J, Knowles DM, Moore PS 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 266: 1865-1869.
12. Chang Y, Moore PS, Talbot S.J., Boshoff CH, Zarkowska T, Godden K, Paterson H., Weiss RA, Mittnacht S. 1996. Cyclin encoded by KS herpesvirus. Nature. 382: 410.
13. Cheng X, Cole RN, Zaia J, Hart GW 2000. Alternative O-glycosylation/O- phosphorylation of the murine estrogen receptor beta. Biochemistry. 39: 11609-11620.
14. Cheng X, Hart GW 2001. Alternative O-glycosylation/O-phosphorylation of serine-16 in murine estrogen receptor beta. Post-translational regulation of turnover and transactivation activity. J Biol Chem. 276: 10570-10575.
15. Chiou CJ, Poole LJ, Kim P.S., Ciufo DM, Cannon JS, ap Rhys CM, Alcendor DJ, Zong JC, Ambinder RF, Hayward GS 2002. Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus. J Virol. 76: 3421-3439.
16. Choi JK, Lee BS, Shim S.N., Li M., Jung JU 2000. Identification of the novel K15 gene at the rightmost end of the Kaposi's sarcoma-associated herpesvirus genome. J Virol. 74: 436-446.
17. Chou T-Y, Hart G.W., Dang CV 1995. c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas. J Biol Chem. 270: 18961-18965.
18. Chung YH, Means RE, Choi J.K., Lee BS, Jung JU 2002. Kaposi's sarcoma-associated herpesvirus OX2 glycoprotein activates myeloid-lineage cells to induce inflammatory cytokine production. J Virol. 76: 4688-4698.
19. Cinquina CC, Grogan E, Sun R., Lin S-F, Beardsley GP, Miller G. 2000. Dihydrofolate reductase from Kaposi's sarcomaaAssociated herpesvirus. Virology. 268: 201-217.
20. Cole RN, Hart GW 1999. Glycosylation sites flank phosphorylation sites on synapsin I: O-linked N-acetylglucosamine residues are localized within domains mediating synapsin I interactions. J Neurochem. 73: 418-428.
21. Comer FI, Hart GW 2001. Reciprocity between O-GlcNAc and O-phosphate on the carboxyl terminal domain of RNA polymerase II. Biochemistry. 40: 7845-7852.
22. Coscoy L, Ganem D. 2000. Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc Natl Acad Sci USA. 97: 8051-8056.
23. Deng B, O'Connor CM, Kedes DH, Zhou ZH 2007. Direct visualization of the putative portal in the Kaposi's sarcoma-associated herpesvirus capsid by cryoelectron tomography. J Virol. 81: 3640-3644.
24. Drougat L, Olivier-Van Stichelen S, Mortuaire M, Foulquier F, Lacoste A-S, Michalski J-C, Lefebvre T, Vercoutter-Edouart A-S. 2012. Characterization of O-GlcNAc cycling and proteomic identification of differentially O-GlcNAcylated proteins during G1/S transition. Biochim Biophys Acta Gen Subj. 1820: 1839-1848.
25. Dyson OF, Traylen CM, Akula SM 2010. Cell Membrane-bound Kaposi's sarcoma-associated herpesvirus-encoded glycoprotein B promotes virus latency by regulating expression of cellular Egr-1. J Biol Chem. 285: 37491-37502.
26. Feng P, Park J, Lee B.S., Lee SH, Bram RJ, Jung JU 2002. Kaposi's sarcoma-associated herpesvirus mitochondrial K7 protein targets a cellular calcium-modulating cyclophilin ligand to modulate intracellular calcium concentration and inhibit apoptosis. J Virol. 76: 11491-11504.
27. Field N, Low W, Daniels M., Howell S, Daviet L, Boshoff C., Collins M. 2003. KSHV vFLIP binds to IKK-gamma to activate IKK. J Cell Sci. 116: 3721-3728.
28. Gao SJ, Boshoff C, Jayachandra S., Weiss RA, Chang Y, Moore PS 1997. KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene. 15: 1979-1985.
29. Gill MB, Edgar R, May J.S., Stevenson PG 2008. A gamma-herpesvirus glycoprotein complex manipulates actin to promote viral spread. PLoS One. 3: e1808.
30. Glaunsinger B, Chavez L, Ganem D. 2005. The exonuclease and host shutoff functions of the SOX protein of Kaposi's sarcoma-associated herpesvirus are genetically separable. J Virol. 79: 7396-7401.
31. Glenn M, Rainbow L, Aurade F., Davison A, Schulz TF 1999. Identification of a spliced gene from Kaposi's sarcoma-associated herpesvirus encoding a protein with similarities to latent membrane proteins 1 and 2A of Epstein-Barr virus. J Virol. 73: 6953-6963.
32. Golks A, Tran TT, Goetschy J.F., Guerini D. 2007. Requirement for O-linked N-acetylglucosaminyltransferase in lymphocytes activation. EMBO J. 26: 4368-4379.
33. Gonzalez SA, Burrone OR 1991. Rotavirus NS26 is modified by addition of single O-linked residues of N-acetylglucosamine. Virology. 182: 8-16.
34. González C.M., Wang L, Damania B. 2009. Kaposi's sarcoma-associated herpesvirus encodes a viral deubiquitinase. J Virol. 83: 10224-10233.
35. Gonzalez CM, Wong EL, Bowser B.S., Hong GK, Kenney S, Damania B. 2006. Identification and characterization of the Orf49 protein of Kaposi's sarcoma-associated herpesvirus. J Virol. 80: 3062-3070.
36. Gregory SM, Davis BK, West J.A., Taxman DJ, Matsuzawa S-i, Reed JC, Ting JPY, Damania B. 2011. Discovery of a viral NLR homolog that inhibits the inflammasome. Science. 331: 330-334.
37. Greis KD, Gibson W, Hart GW 1994. Site-specific glycosylation of the human cytomegalovirus tegument basic phosphoprotein (UL32) at serine 921 and serine 952. J Virol. 68: 8339-8349.
38. Guo H, Wang L, Peng L., Zhou ZH, Deng H. 2009. Open reading frame 33 of a gammaherpesvirus encodes a tegument protein essential for virion morphogenesis and egress. J Virol. 83: 10582-10595.
39. Gupta R, Brunak S. 2002. Prediction of glycosylation across the human proteome and the correlation to protein function. Pac Symp Biocomput. 310-322.
40. Gustafson EA, Schinazi RF, Fingeroth JD 2000. Human herpesvirus 8 open reading frame 21 is a thymidine and thymidylate kinase of narrow substrate specificity that efficiently phosphorylates zidovudine but not ganciclovir. J Virol. 74: 684-692.
41. Hamza MS, Reyes RA, Izumiya Y, Wisdom R., Kung HJ, Luciw PA 2004. ORF36 protein kinase of Kaposi's sarcoma herpesvirus activates the c-Jun N-terminal kinase signaling pathway. J Biol Chem. 279: 38325-38330.
42. Han Z, Swaminathan S. 2006. Kaposi's sarcoma-associated herpesvirus lytic gene ORF57 is essential for infectious virion production. J Virol. 80: 5251-5260.
43. Hart GW. 1997. Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins. Ann Rev Biochem. 66: 315-335.
44. Heinzelmann K, Scholz BA, Nowak A, Fossum E., Kremmer E, Haas J, Frank R., Kempkes B. 2010. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4/K10) is a novel interaction partner of CSL/CBF1, the major downstream effector of Notch signaling. J Virol. 84: 12255-12264.
45. Hyun TS, Subramanian C, Cotter M.A., 2nd, Thomas RA, Robertson ES. 2001. Latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus interacts with Tat and activates the long terminal repeat of human immunodeficiency virus type 1 in human cells. J Virol. 75: 8761-8771.
46. Ishido S, Wang C, Lee B.S., Cohen GB, Jung JU 2000. Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J Virol. 74: 5300-5309.
47. Isono T. 2011. O-GlcNAc-specific antibody CTD110.6 cross-reacts with N-GlcNAc2-modified proteins induced under glucose deprivation. PLoS One. 6: e18959.
48. Iyer SP, Hart GW 2003. Dynamic nuclear and cytoplasmic glycosylation: Enzymes of O-GlcNAc cycling. Biochemistry. 42: 2493-2499.
49. Jackson SP, Tjian R. 1988. O-glycosylation of eukaryotic transcription factors: Implications for mechanisms of transcriptional regulation. Cell. 55: 125-133.
50. Jia Q, Wu TT, Liao H.I., Chernishof V., Sun R. 2004. Murine gammaherpesvirus 68 open reading frame 31 is required for viral replication. J Virol. 78: 6610-6620.
51. Jochmann R, Thurau M, Jung S., Hofmann C, Naschberger E, Kremmer E., Harrer T, Miller M, Schaft N., Stürzl M. 2009. O-linked N-acetylglucosaminylation of Sp1 inhibits the human immunodeficiency virus type-1 promoter. J Virol. 83: 3704-3718.
52. Kamemura K, Hart GW 2003. Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: A new paradigm for metabolic control of signal transduction and transcription. Prog Nucleic Acid Res Mol Biol. 73: 107-136.
53. Kelly WG, Dahmus ME, Hart GW 1993. RNA polymerase II is a glycoprotein. Modification of the COOH-terminal domain by O-GlcNAc. J Biol Chem. 268: 10416-10424.
54. Kliche S, Nagel W, Kremmer E., Atzler C, Ege A, Knorr T., Koszinowski U, Kolanus W, Haas J. 2001. Signaling by human herpesvirus 8 kaposin A through direct membrane recruitment of cytohesin-1. Mol Cell. 7: 833-843.
55. Ko YC, Tsai WH, Wang P.W., Wu IL, Lin SY, Chen YL, Chen J.Y., Lin SF 2012. Suppressive regulation of KSHV RTAwith O-GlcNAcylation. JBiomed Sci. 19: 12.
56. Konrad A, Wies E, Thurau M., Marquardt G, Naschberger E, Hentschel S., Jochmann R, Schulz TF, Erfle H, Brors B., et al 2009. A systems biology approach to identify the combination effects of human herpesvirus 8 genes on NF-kappaB activation. J Virol. 83: 2563-2574.
57. Kremmer E, Sommer P, Holzer D., Galetsky SA, Molochkov VA, Gurtsevitch V, Winkelmann C., Lisner R, Niedobitek G, Grasser FA 1999. Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) ORF54 encodes a functional dUTPase expressed in the lytic replication cycle. J Gen Virol. 80 (Pt 5): 1305-1310.
58. Krithivas A, Young DB, Liao G, Greene D., Hayward SD 2000. Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells. J Virol. 74: 9637-9645.
59. Krzeslak A, Pomorski L, Lipinska A. 2010. Elevation of nucleocytoplasmic beta-N-acetylglucosaminidase (O-GlcNAcase) activity in thyroid cancers. Int J Mol Med. 25: 643-648.
60. Lagos D, Trotter MW, Vart R.J., Wang HW, Matthews NC, Hansen A, Flore O., Gotch F, Boshoff C. 2007. Kaposi sarcoma herpesvirus-encoded vFLIP and vIRF1 regulate antigen presentation in lymphatic endothelial cells. Blood. 109: 1550-1558.
61. Lee HR, Toth Z, Shin Y.C., Lee JS, Chang H, Gu W, Oh T.K., Kim MH, Jung JU 2009. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 targets MDM2 to deregulate the p53 tumor suppressor pathway. J Virol. 83: 6739-6747.
62. Li H, Komatsu T, Dezube B.J., Kaye KM 2002. The Kaposi's sarcoma-associated herpesvirus K12 transcript from a primary effusion lymphoma contains complex repeat elements, is spliced, and initiates from a novel promoter. J Virol. 76: 11880-11888.
63. Li M, Lee H, Yoon D.W., Albrecht JC, Fleckenstein B, Neipel F, Jung JU 1997. Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin. J Virol. 71: 1984-1991.
64. Li M, MacKey J, Czajak S.C., Desrosiers RC, Lackner AA, Jung JU 1999. Identification and characterization of Kaposi's sarcoma-associated herpesvirus K8.1 virion glycoprotein. J Virol. 73: 1341-1349.
65. Lin K, Dai CY, Ricciardi RP 1998. Cloning and functional analysis of Kaposi's sarcoma-associated herpesvirus DNA polymerase and its processivity factor. J Virol. 72: 6228-6232.
66. Liu L, Eby MT, Rathore N, Sinha S.K., Kumar A., Chaudhary PM 2002. The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Ikappa B kinase complex. J Biol Chem. 277: 13745-13751.
67. Love DC, Hanover JA 2005. The Hexosamine signaling pathway: Deciphering the "O-GlcNAc Code". Sci STKE. 2005: re13.
68. Love DC, Krause MW, Hanover JA 2010. O-GlcNAc cycling: Emerging roles in development and epigenetics. Semin CellDev Biol. 21: 646-654.
69. Lubyova B, Kellum MJ, Frisancho A.J., Pitha PM 2004. Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 stimulates the transcriptional activity of cellular IRF-3 and IRF-7. J Biol Chem. 279: 7643-7654.
70. Lukac DM, Renne R, Kirshner J.R., Ganem D. 1998. Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology. 252: 304-312.
71. Martin DF, Kuppermann BD, Wolitz R.A., Palestine AG, Li H, Robinson CA 1999. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. N Engl J Med. 340: 1063-1070.
72. May JS, de Lima BD, Colaco S, Stevenson PG 2005. Intercellular gamma-herpesvirus dissemination involves co-ordinated intracellular membrane protein transport. Traffic. 6: 780-793.
73. Medina L, Grove K, Haltiwanger RS 1998. SV40 large T antigen is modified with O-linked N-acetylglucosamine but not with other forms of glycosylation. Glycobiology. 8: 383-391.
74. Mullis KG, Haltiwanger RS, Hart G.W., Marchase RB, Engler JA 1990. Relative accessibility of N-acetylglucosamine in trimers of the adenovirus types 2 and 5 fiber proteins. J Virol. 64: 5317-5323.
75. Mutocheluh M, Hindle L, Areste C., Chanas SA, Butler LM, Lowry K, Shah K., Evans DJ, Blackbourn DJ 2011. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor-2 inhibits type 1 interferon signalling by targeting interferon-stimulated gene factor-3. J Gen Virol. 92: 2394-2398.
76. Nakano K, Isegawa Y, Zou P., Tadagaki K, Inagi R, Yamanishi K. 2003. Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded vMIP-I and vMIP-II induce signal transduction and chemotaxis in monocytic cells. Arch Virol. 148: 871-890.
77. Naranatt PP, Akula SM, Chandran B. 2002. Characterization of gamma2-human herpesvirus-8 glycoproteins gH and gL. Arch Virol. 147: 1349-1370.
78. Nascimento R, Dias JD, Parkhouse RM 2009. The conserved UL24 family of human alpha, beta and gamma herpesviruses induces cell cycle arrest and in-activation of the cyclinB/cdc2 complex. Arch Virol. 154: 1143-1149.
79. Nealon K, Newcomb WW, Pray T.R., Craik CS, Brown JC, Kedes DH 2001. Lytic replication of Kaposi's sarcoma-associated herpesvirus results in the formation of multiple capsid species: Isolation and molecular characterization of A, B, and C capsids from a gammaherpesvirus. J Virol. 75: 2866-2878.
80. Nicholas J, Ruvolo V, Zong J., Ciufo D, Guo HG, Reitz M.S., Hayward GS 1997. A single 13-kilobase divergent locus in the Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genome contains nine open reading frames that are homologous to or related to cellular proteins. J Virol. 71: 1963-1974.
81. Noach N, Segev Y, Levi I., Segal S, Priel E. 2007. Modification of topoisomerase I activity by glucose and by O-glcnacylation of the enzyme protein. Glycobiology. 17: 1357-1364.
82. Novelli A, Boulanger PA 1991. Deletion analysis of functional domains in baculovirus-expressed adenovirus type 2 fiber. Virology. 185: 365-376.
83. O'Connor C.M., Kedes DH 2006. Mass spectrometric analyses of purified rhesus monkey rhadinovirus reveal 33 virion-associated proteins. J Virol. 80: 1574-1583.
84. Ojala PM, Yamamoto K, Castanos-Velez E, Biberfeld P., Korsmeyer SJ, Makela TP 2000. The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2. Nat Cell Biol. 2: 819-825.
85. Olsen JV, de Godoy LM, Li G, Macek B, Mortensen P., Pesch R, Makarov A, Lange O., Horning S, Mann M. 2005. Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap. Mol Cell Proteomics. 4: 2010-2021.
86. Osborne J, Moore PS, Chang Y. 1999. KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways. Hum Immunol. 60: 921-927.
87. Ozgur S, Damania B, Griffith J. 2011. The Kaposi's sarcoma-associated herpesvirus ORF6 DNA binding protein forms long DNA-free helical protein filaments. J Struct Biol. 174: 37-43.
88. Park J, Lee D, Seo T., Chung J, Choe J. 2000. Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) open reading frame 36 protein is a serine protein kinase. J Gen Virol. 81: 1067-1071.
89. Pati S, Cavrois M, Guo H.G., Foulke JS, Jr, Kim J, Feldman RA, Reitz M. 2001. Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: Evidence for a paracrine model of Kaposi's sarcoma pathogenesis. J Virol. 75: 8660-8673.
90. Perkins EM, Anacker D, Davis A., Sankar V, Ambinder RF, Desai P. 2008. Small capsid protein pORF65 is essential for assembly of Kaposi's sarcoma-associated herpesvirus capsids. J Virol. 82: 7201-7211.
91. Pertel PE, Spear PG, Longnecker R. 1998. Human herpesvirus-8 glycoprotein B interacts with Epstein-Barr virus (EBV) glycoprotein 110 but fails to complement the infectivity of EBV mutants. Virology. 251: 402-413.
92. Ranuncolo SM, Ghosh S, Hanover J.A., Hart GW, Lewis BA 2012. Evidence of the involvement of O-GlcNAc-modified human RNA polymerase II CTD in transcription in vitro and in vivo. J Biol Chem. 287: 23549-23561.
93. Renne R, Barry C, Dittmer D., Compitello N, Brown PO, Ganem D. 2001. Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Virol. 75: 458-468.
94. Roos MD, Su K, Baker J.R., Kudlow JE 1997. O glycosylation of an Sp1-derived peptide blocks known Sp1 protein interactions. Mol Cell Biol. 17: 6472-6480.
95. Rose TM, Ryan JT, Schultz E.R., Raden BW, Tsai C-C. 2003. Analysis of 4.3 kilobases of divergent locus B of macaque retroperitoneal fibromatosis- associated herpesvirus reveals a close similarity in gene sequence and genome organization to Kaposi's sarcoma associated herpesvirus. J Virol. 77: 5084-5097.
96. Russo JJ, Bohenzky RA, Chien M.C., Chen J., Yan M, Maddalena D, Parry J.P., Peruzzi D., Edelman IS, Chang Y, et al 1996. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci USA. 93: 14862-14867.
97. Sakabe K, Wang Z, Hart GW 2010. Beta-N-acetylglucosamine (O-GlcNAc) is part of the histone code. Proc Natl Acad Sci USA. 107: 19915-19920.
98. Sanchez DJ, Coscoy L, Ganem D. 2002. Functional organization of MIR2, a novel viral regulator of selective endocytosis. J Biol Chem. 277: 6124-6130.
99. Sander G, Konrad A, Thurau M., Wies E, Leubert R, Kremmer E., Dinkel H, Schulz T, Neipel F., Stürzl M. 2008. Intracellular localization map of human herpesvirus 8 proteins. J Virol. 82: 1908-1922.
100. Santarelli R, Farina A, Granato M., Gonnella R, Raffa S, Leone L., Bei R, Modesti A, Frati L., Torrisi MR, et al 2008. Identification and characterization of the product encoded by ORF69 of Kaposi's sarcoma-associated herpesvirus. J Virol. 82: 4562-4572.
101. Seo T, Park J, Choe J. 2005. Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 1 inhibits transforming growth factor-beta signaling. Cancer Res. 65: 1738-1747.
102. Seo T, Park J, Lee D., Hwang SG, Choe J. 2001. Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus binds to p53 and represses p53-dependent transcription and apoptosis. J Virol. 75: 6193-6198.
103. Sharp TV, Wang HW, Koumi A, Hollyman D., Endo Y, Ye H, Du M.Q., Boshoff C. 2002. K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function. J Virol. 76: 802-816.
104. Shevchenko A, Wilm M, Vorm O., Mann M. 1996. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem. 68: 850-858.
105. Slawson C, Hart GW 2003. Dynamic interplay between O-GlcNAc and O-phosphate: The sweet side of protein regulation. Curr Opin Struct Biol. 13: 631-636.
106. Slawson C, Hart GW 2011. O-GlcNAc signalling: Implications for cancer cell biology. Nat Rev Cancer. 11: 678-684.
107. Slawson C, Pidala J, Potter R. 2001. Increased N-acetyl-beta- glucosaminidase activity in primary breast carcinomas corresponds to a decrease in N-acetylglucosamine containing proteins. Biochim Biophys Acta. 1537: 147-157.
108. Slawson C, Zachara NE, Vosseller K, Cheung W.D., Lane MD, Hart GW 2005. Perturbations in O-linked {beta}-N-acetylglucosamine protein modification cause severe defects in mitotic progression and cytokinesis. J Biol Chem. 280: 32944-32956.
109. Spiller OB, Robinson M, O'Donnell E, Milligan S, Morgan B.P., Davison AJ, Blackbourn DJ 2003. Complement regulation by Kaposi's sarcoma-associated herpesvirus ORF4 protein. J Virol. 77: 592-599.
110. Stürzl M., Gaus D, Dirks W.G., Ganem D., Jochmann R. 2013. Kaposi's sarcoma-derived cell line SLK is not of endothelial origin, but is a contaminant from a known renal carcinoma cell line. Int J Cancer. 132: 1954-1958.
111. Thurau M, Marquardt G, Gonin-Laurent N, Weinlander K., Naschberger E, Jochmann R, Alkharsah K.R., Schulz TF, Thome M, Neipel F, et al 2008. The viral inhibitor of apoptosis vFLIP/K13 protects endothelial cells against superoxide-induced cell death. J Virol. 83: 598-611.
112. Unal A, Pray TR, Lagunoff M, Pennington M.W., Ganem D., Craik CS 1997. The protease and the assembly protein of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8). J Virol. 71: 7030-7038.
113. Vieira J, O'Hearn PM. 2004. Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. Virology. 325: 225-240.
114. Wang SS, Chang PJ, Chen L.W., Chen LY, Hung CH, Liou JY, Yen JB 2012. Positive and negative regulation in the promoter of the ORF46 gene of Kaposi's sarcoma-associated herpesvirus. Virus Res. 165: 157-169.
115. Wang S, Huang X, Sun D., Xin X, Pan Q, Peng S., Liang Z, Luo C, Yang Y., Jiang H, et al 2012. Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates Akt signaling. PLoS One. 7: e37427.
116. Wang HW, Sharp TV, Koumi A, Koentges G., Boshoff C. 2002. Characterization of an anti-apoptotic glycoprotein encoded by Kaposi's sarcoma-associated herpesvirus which resembles a spliced variant of human survivin. EMBO J. 21: 2602-2615.
117. Wang Z, Udeshi ND, Slawson C, Compton P.D., Sakabe K., Cheung WD, Shabanowitz J, Hunt DF, Hart GW 2010. Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates cytokinesis. Science Signaling. 3: ra2.
118. Wang L, Wakisaka N, Tomlinson C.C., DeWire SM, Krall S, Pagano JS, Damania B. 2004. The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors. Cancer Res. 64: 2774-2781.
119. Whitford M, Faulkner P. 1992. A structural polypeptide of the baculovirus Autographa californica nuclear polyhedrosis virus contains O-linked N-acetylglucosamine. J Virol. 66: 3324-3329.
120. Wies E, Hahn AS, Schmidt K, Viebahn C., Rohland N, Lux A, Schellhorn T., Holzer A, Jung JU, Neipel F. 2009. The Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 inhibits cellular IRF-5. J Biol Chem. 284: 8525-8538.
121. Wu FY, Ahn J-H, Alcendor DJ, Jang W-J, Xiao J, Hayward S.D., Hayward GS 2001. Origin-independent assembly of Kaposi's sarcoma-associated herpesvirus DNA replication compartments in transient cotransfection assays and association with the ORF-K8 protein and cellular PML. J Virol. 75: 1487-1506.
122. Wu TT, Park T, Kim H., Tran T, Tong L, Martinez-Guzman D, Reyes N., Deng H, Sun R. 2009. ORF30 and ORF34 are essential for expression of late genes in murine gammaherpesvirus 68. J Virol. 83: 2265-2273.
123. Xi X, Persson LM, O'Brien MW, Mohr I, Wilson AC 2012. Cooperation between viral interferon regulatory factor 4 and RTA to activate a subset of Kaposi's sarcoma-associated herpesvirus lytic promoters. J Virol. 86: 1021-1033.
124. Yang YR, Song M, Lee H., Jeon Y, Choi E-J, Jang H-J, Moon HY, Byun H-Y, Kim E-K, Kim DH, et al. 2012. O-GlcNAcase is essential for embryonic development and maintenance of genomic stability. Aging Cell. 11: 439-448.
125. Yang X, Zhang F, Kudlow JE 2002. Recruitment of O-GlcNAc transferase to promoters by corepressor mSin3A: Coupling protein O-GlcNAcylation to transcriptional repression. Cell. 110: 69-80.
126. Zachara NE, Hart GW 2004. O-GlcNAc a sensor of cellular state: The role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress. Biochim Biophys Acta Gen Subj. 1673: 13-28.
127. Zachara NE, Hart GW 2006. Cell signaling, the essential role of O-GlcNAc! Biochim Biophys Acta Mol Cell Biol Lipids. 1761: 599-617.
128. Zachara NE, Molina H, Wong K.Y., Pandey A., Hart GW 2011. The dynamic stress-induced "O-GlcNAc-ome" highlights functions for O-GlcNAc in regulating DNA damage/repair and other cellular pathways. Amino Acids. 40: 793-808.
129. Zhu FX, Chong JM, Wu L, Yuan Y. 2005. Virion proteins of Kaposi's sarcoma-associated herpesvirus. J Virol. 79: 800-811.
130. Zhu FX, King SM, Smith E.J., Levy DE, Yuan Y. 2002. A Kaposi's sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphorylation and nuclear accumulation. Proc Natl Acad Sci USA. 99: 5573-5578.
131. Zhu FX, Sathish N, Yuan Y. 2010. Antagonism of host antiviral responses by Kaposi's sarcoma-associated herpesvirus tegument protein ORF45. PLoS One. 5: e10573.
132. Zimring JC, Goodbourn S, Offermann MK 1998. Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription. J Virol. 72: 701-707.